COMPARATIVE ANALYSIS OF RISK FACTORS AND SYMPTOMATOLOGY IN HYPERTENSIVE PATIENTS WITH AND WITHOUT ISCHEMIC HEART DISEASE
DOI:
https://doi.org/10.5281/zenodo.17292055Keywords:
Patients were divided into two main clinical groups based on the established diagnosisAbstract
Cardiovascular diseases (CVD) continue to occupy a leading position among the causes of disability and premature death worldwide, causing more than 18 million deaths annually. In the structure of cardiovascular diseases, arterial hypertension (AH) and coronary heart disease (CHD) attract particular attention, which are the main determinants of the development of life-threatening vascular complications [2.4,5].
References
1.Avaryanov A. et al. Hypertension. Diagnosis, prevention, and treatment method. // Centropolygraph. Moscow. - 2019. - P. 191.
2.Ananyeva O.V. Hypertension. Best treatment methods. // Workshop Collection. ARIA - AIF. Moscow. - 2017. - P. 128.
3.Barbarash O.L. et al. The effect of obesity on the prognosis in patients with coronary heart disease: cohort study data // Cardiology. - 2023. - Vol. 63. - No2. - P. 34-41.
4.Osipova E.S. et al. Risk factors for coronary artery stenosis after stenting in women with obesity during menopause. // Russian Cardiology Journal. - 2018. - No. - P. 34-39.
5.Chazova I.E., Zernakova Yu.V. Modern approaches to the treatment of arterial hypertension in patients with coronary heart disease // Therapeutic Archive. - 2021. - Vol. 93. - No6. - P. 678-685.
6.Chumakova G.A. et al. Features of myocardial infarction in patients with obesity. // Russian Cardiology Journal. - 2017. - No. - P. 75-80.
7.Ridker P.M. et al. Inflammation, obesity, and risk of coronary heart disease: a prospective cohort study // The Lancet. - 2015. - V. 385. - P. 123-1241.
8.Rosendorff C. et al. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association // Journal of the American College of Cardiology. - 2015. - V. 65. - P. 1998-2038.
9.Stamler J. et al. Obesity and cardiovascular risk: insights from the Framingham Heart Study // American Journal of Cardiology. - 2019. - V. 123. - P. 145-152.
